MAY 14, 2018 1:50 PM PDT

Early Differences Between Benign and Malignant Tumors

WRITTEN BY: Kara Marker

Physicians are in need of a dependable diagnostic approach for distinguishing between benign and malignant tumors early-on. Once doctors can rule out that a tumor is malignant, they can save a patient from undergoing the often harsh, grueling treatments prescribed to treat malignant cancer.

Micrograph of lymph node with colorectal carcinoma. Credit: Wikimedia user Nephron

In a new study from scientists at the Duke University Medical Center, clear differences have been observed between early benign and early malignant tumors. Researchers found that malignant cancers are “born to be bad,” and they are working on identifying what makes them “bad” as soon as possible.

"We found evidence that benign and malignant tumors start differently, and that cell movement - an important feature of malignancy - manifests itself very early on during tumor growth," explained lead author Marc D. Ryser, PhD.

Abnormal cell movement is what causes tumors to spread, or metastasize, to different tissues, which makes them more dangerous. In the past, research has shown that significant qualities of a tumor are present in the genome from start to finish. In the new study, researcher analyzed 19 human colorectal tumors with both genome sequencing technology and mathematical simulation models.

They successfully identified signatures of early abnormal cell movement in nine out of 15 invasive samples. No early abnormal cell movement was detected in the four benign tumors. Ryser and the others acknowledge that they need to confirm their findings in a larger study.

"Thanks to improved screening technologies, we diagnose more and more small tumors," explained senior author Darryl Shibata, MD. "Because treating a patient aggressively can cause them harm and side-effects, it is important to understand which of the small screen-detected tumors are relatively benign and slowly growing, and which ones are born to be bad."

Indeed, the key clinical application that the study scientists want to develop as a result of their research is to test small tumors that have been detected by a cancer screening for early cell movement that could indicate malignancy. The ultimate goal? Save the aggressive therapies for the people who actually need it.

The present study was published in the journal Proceedings of the National Academy of Sciences.

Source: Duke University Medical Center

About the Author
I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JUL 01, 2022
Cell & Molecular Biology
Avoiding Eco-Fatigue
JUL 01, 2022
Avoiding Eco-Fatigue
Written by John Winsor The scientific industry is massive, with millions of lab workers generating biohazard bags full o ...
JUL 01, 2022
Clinical & Molecular DX
Could Temperature Fight Obesity? Study in Mice Suggests Cold Exposure Could
JUL 01, 2022
Could Temperature Fight Obesity? Study in Mice Suggests Cold Exposure Could
Mammals, including humans, have at least two different types of fat tissue. White fat is the tissue where energy is prim ...
JUL 07, 2022
Cancer
Study Suggests Breast Cancer Spreads while Sleeping
JUL 07, 2022
Study Suggests Breast Cancer Spreads while Sleeping
Breast cancer remains the second leading cause of cancer-related death in women in the United States, and experts expect ...
JUL 04, 2022
Coronavirus
Some Neurodegenerative Diseases are More Likely After COVID-19
JUL 04, 2022
Some Neurodegenerative Diseases are More Likely After COVID-19
European researchers analyzed the health records of about half the entire population of Denmark, which included 919,731 ...
JUL 13, 2022
Clinical & Molecular DX
Nipah Virus: Moderna Invests in a Vaccine for the Virus that Fauci Calls a 'Pandemic Threat'
JUL 13, 2022
Nipah Virus: Moderna Invests in a Vaccine for the Virus that Fauci Calls a 'Pandemic Threat'
In Malaysia in the fall of 1998, a mystery ailment swept through the local pig-farming community, eventually leading to ...
JUL 21, 2022
Immunology
For the First Time, Microscopy Catches Antibodies Attacking a Receptor
JUL 21, 2022
For the First Time, Microscopy Catches Antibodies Attacking a Receptor
Using cryo-electron microscopy, researchers captured images of a molecule called an autoantibody as it attached to a rec ...
Loading Comments...